Cytokinetics, Inc. (CYTK)
74.70
-1.15
(-1.52%)
USD |
NASDAQ |
May 18, 10:15
Cytokinetics Total Assets (Quarterly) : 1.273B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 86.48B |
| Regeneron Pharmaceuticals, Inc. | 40.87B |
| Sarepta Therapeutics, Inc. | 3.179B |
| Moderna, Inc. | 11.49B |
| Revolution Medicines, Inc. | 2.254B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.100B |
| Shareholders Equity (Quarterly) | -826.57M |
| Debt to Equity Ratio | -1.559 |
| Current Ratio | 4.214 |
| Net Debt Paydown Yield | -1.22% |